Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00163592

Enrollment

Registered

2005-09-14

Start date

2003-09-30

Completion date

2004-02-29

Last updated

2006-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Vascular Anastomosis

Keywords

Vascular reconstruction, Polytetraflouroethylene (PTFE) prosthesis

Brief summary

This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.

Interventions

DRUGTissucol®

PROCEDUREControl: Conventional treatment, i.e. compression with swabs

Study design

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Inclusion criteria

Subjects with femoral vascular anastomosis and bleeding suture holes after vessel reconstruction with a PTFE prosthesis

Countries

Austria, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026